La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

K-One Technology Berhad Crescita futura

Future criteri di controllo 0/6

Al momento non disponiamo di una copertura analitica sufficiente per prevedere la crescita e il fatturato di K-One Technology Berhad.

Informazioni chiave

n/a

Tasso di crescita degli utili

n/a

Tasso di crescita dell'EPS

Electronic crescita degli utili	24.3%
Tasso di crescita dei ricavi	n/a
Rendimento futuro del capitale proprio	n/a
Copertura analitica	None
Ultimo aggiornamento	n/a

Aggiornamenti recenti sulla crescita futura

Nessun aggiornamento

Recent updates

Optimistic Investors Push K-One Technology Berhad (KLSE:K1) Shares Up 75% But Growth Is Lacking

Jul 12

K-One Technology Berhad's (KLSE:K1) 28% Share Price Surge Not Quite Adding Up

May 27

A Look At The Intrinsic Value Of K-One Technology Berhad (KLSE:K1)

Nov 03

We Think K-One Technology Berhad (KLSE:K1) Can Easily Afford To Drive Business Growth

May 09

We're Not Very Worried About K-One Technology Berhad's (KLSE:K1) Cash Burn Rate

Oct 26

Here's Why We're Not Too Worried About K-One Technology Berhad's (KLSE:K1) Cash Burn Situation

Jun 13

Key Things To Understand About K-One Technology Berhad's (KLSE:K1) CEO Pay Cheque

Nov 30

In questa sezione di solito presentiamo le proiezioni di crescita dei ricavi e degli utili basate sulle stime di consenso degli analisti professionisti per aiutare gli investitori a capire la capacità della società di generare profitti. Tuttavia, poiché K-One Technology Berhad non ha fornito dati sufficienti sul passato e non ha previsioni degli analisti, i suoi utili futuri non possono essere calcolati in modo affidabile estrapolando i dati passati o utilizzando le previsioni degli analisti.

Si tratta di una situazione piuttosto rara, dato che il 97% delle società coperte da SimplyWall St dispone di dati finanziari passati.

Previsioni di crescita degli utili e dei ricavi

KLSE:K1 - Stime future degli analisti e dati finanziari passati (MYR Millions )
Data	Ricavi	Guadagni	Flusso di cassa libero	Liquidità dell'operazione	Avg. Numero di analisti
3/31/2024	171	3	6	13	N/A
12/31/2023	167	0	10	16	N/A
9/30/2023	173	-2	15	18	N/A
6/30/2023	176	2	6	10	N/A
3/31/2023	168	-1	0	4	N/A
12/31/2022	165	0	-4	-1	N/A
9/30/2022	154	-3	-14	-11	N/A
6/30/2022	133	-7	-12	-10	N/A
3/31/2022	133	-3	-11	-9	N/A
12/31/2021	126	-3	-10	-9	N/A
9/30/2021	121	-6	-5	-1	N/A
6/30/2021	121	-3	-1	4	N/A
3/31/2021	105	-8	-4	0	N/A
12/31/2020	91	-9	0	5	N/A
9/30/2020	87	-1	2	5	N/A
6/30/2020	90	0	0	2	N/A
3/31/2020	96	4	5	8	N/A
12/31/2019	97	6	1	7	N/A
9/30/2019	89	7	-2	3	N/A
6/30/2019	82	8	-1	5	N/A
3/31/2019	73	7	-3	1	N/A
12/31/2018	74	6	-2	0	N/A
9/30/2018	74	1	-3	-2	N/A
6/30/2018	74	0	-5	-4	N/A
3/31/2018	77	-1	-6	-6	N/A
12/31/2017	78	-10	N/A	2	N/A
9/30/2017	81	-14	N/A	9	N/A
6/30/2017	80	-17	N/A	8	N/A
3/31/2017	80	-17	N/A	5	N/A
12/31/2016	82	-9	N/A	2	N/A
9/30/2016	95	1	N/A	3	N/A
6/30/2016	117	8	N/A	6	N/A
3/31/2016	136	9	N/A	11	N/A
12/31/2015	146	11	N/A	7	N/A
9/30/2015	166	11	N/A	15	N/A
6/30/2015	174	9	N/A	20	N/A
3/31/2015	173	9	N/A	24	N/A
12/31/2014	186	12	N/A	30	N/A
9/30/2014	184	10	N/A	21	N/A
6/30/2014	182	9	N/A	16	N/A
3/31/2014	181	10	N/A	18	N/A
12/31/2013	171	1	N/A	15	N/A
9/30/2013	159	-5	N/A	14	N/A

Previsioni di crescita futura degli analisti

Guadagni vs tasso di risparmio: Dati insufficienti per determinare se la crescita degli utili prevista K1 è superiore al tasso di risparmio ( 3.6% ).

Guadagni vs Mercato: Dati insufficienti per determinare se si prevede che gli utili di K1 cresceranno più velocemente del mercato MY

Guadagni ad alta crescita: Dati insufficienti per determinare se si prevede che gli utili di K1 cresceranno in modo significativo nei prossimi 3 anni.

Ricavi vs Mercato: Dati insufficienti per determinare se si prevede che i ricavi di K1 cresceranno più rapidamente del mercato MY.

Ricavi ad alta crescita: Dati insufficienti per determinare se si prevede che i ricavi di K1 cresceranno più rapidamente di 20% all'anno.

Previsioni di crescita dell'utile per azione

Rendimento futuro del capitale proprio

ROE futuro: Dati insufficienti per determinare se il Return on Equity di K1 è previsto essere elevato tra 3 anni

K-One Technology Berhad Crescita futura

Future criteri di controllo 0/6

Informazioni chiave

Aggiornamenti recenti sulla crescita futura

Recent updates

Optimistic Investors Push K-One Technology Berhad (KLSE:K1) Shares Up 75% But Growth Is Lacking

K-One Technology Berhad Announces Resignation of Wong Youn Kim as Company Secretary

First quarter 2024 earnings released: EPS: RM0.002 (vs RM0.001 loss in 1Q 2023)

K-One Technology Berhad's (KLSE:K1) 28% Share Price Surge Not Quite Adding Up

K-One Technology Berhad, Annual General Meeting, Jun 19, 2024

New major risk - Revenue and earnings growth

K-One Technology Berhad Appoints Wong Mee Kiat as Joint Secretary

Full year 2023 earnings released: EPS: RM0 (vs RM0 in FY 2022)

Third quarter 2023 earnings released: RM0.002 loss per share (vs RM0.002 profit in 3Q 2022)

New minor risk - Share price stability

A Look At The Intrinsic Value Of K-One Technology Berhad (KLSE:K1)

Now 20% undervalued after recent price drop

K-One Meditech Sdn Bhd Receives Approval from the Medical Device Authority Under the Ministry of Health, Malaysia for Registration of Diversey's Oxivir Excel Disinfectant Wipes Used for Cleaning Surfaces and Equipment

Second quarter 2023 earnings released: EPS: RM0 (vs RM0.003 loss in 2Q 2022)

First quarter 2023 earnings released: EPS: RM0 (vs RM0.001 in 1Q 2022)

K-One Technology Berhad Announces Cessation of Office of Loi Kim Fah as Independent and Non Executive Chairman of Risk Committee

K-One Technology Berhad Announces Cessation of GOH CHONG CHUANG as Independent and Non Executive Chairman of Nomination Committee

We Think K-One Technology Berhad (KLSE:K1) Can Easily Afford To Drive Business Growth

Full year 2022 earnings released: EPS: RM0 (vs RM0.003 loss in FY 2021)

Third quarter 2022 earnings released: EPS: RM0.002 (vs RM0.003 loss in 3Q 2021)

Insufficient new directors

We're Not Very Worried About K-One Technology Berhad's (KLSE:K1) Cash Burn Rate

Medical Device Authority of Malaysia Grants Approval to K-One Meditech Sdn Bhd to Distribute Silicone Adhesive Tape Primarily Used for Wound Care Dressing

K-One Technology Berhad Provides Impairment of Plant and Equipment for the Second Quarter Ended June 30, 2022

Second quarter 2022 earnings released: RM0.003 loss per share (vs RM0.002 profit in 2Q 2021)

Medical Device Authority (MDA) of Malaysia Approves COVID-19 Antigen Self-Test Kit (Saliva) for Distribution by K-One MediTech Sdn Bhd

K-One Technology Berhad Announces the Appointment of Independent and Non Executive Member of Audit Committee

Here's Why We're Not Too Worried About K-One Technology Berhad's (KLSE:K1) Cash Burn Situation

First quarter 2022 earnings released: EPS: RM0.001 (vs RM0.001 in 1Q 2021)

Insufficient new directors

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

We're Not Worried About K-One Technology Berhad's (KLSE:K1) Cash Burn

Third quarter 2021 earnings: Revenues and EPS in line with analyst expectations

We're Hopeful That K-One Technology Berhad (KLSE:K1) Will Use Its Cash Wisely

Second quarter 2021 earnings released: EPS RM0.002 (vs RM0.004 loss in 2Q 2020)

K-One Technology Berhad Announces Approval of Low Dead Volume Syringes Suitable for Covid-19 Vaccination by Medical Device Authority, Malaysia

Full year 2020 earnings released: RM0.012 loss per share (vs RM0.008 profit in FY 2019)

New 90-day low: RM0.30

Full year 2020 earnings released: RM0.012 loss per share (vs RM0.008 profit in FY 2019)

New 90-day low: RM0.33

Is K-One Technology Berhad's (KLSE:K1) Share Price Gain Of 115% Well Earned?

New 90-day low: RM0.33

Key Things To Understand About K-One Technology Berhad's (KLSE:K1) CEO Pay Cheque

Third quarter 2020 earnings released: EPS RM0.001

G-AsiaPacific (S) Pte Ltd Enters into an Agreement to Provide Amazon Web Services Cloud Services

New 90-day low: RM0.34

K-One Meditech Sdn Bhd Signs License Agreement with Star Syringe, Uk to Manufacture Syringe Safety Needle Cap in Malaysia & Distribute Worldwide

New 90-day low: RM0.35

New 90-day low - RM0.37

First half earnings released

New 90-day high - RM0.59

Previsioni di crescita degli utili e dei ricavi

Previsioni di crescita futura degli analisti

Previsioni di crescita dell'utile per azione

Rendimento futuro del capitale proprio

Scoprire le aziende in crescita